Status:
COMPLETED
The Incretin Effect in Patients With Chronic Pancreatitis
Lead Sponsor:
University Hospital, Gentofte, Copenhagen
Collaborating Sponsors:
University of Copenhagen
Conditions:
Chronic Pancreatitis
Type 2 Diabetes Mellitus
Eligibility:
All Genders
18-80 years
Brief Summary
The phenomenon that oral glucose elicits a higher insulin response than does intravenous (iv) glucose, even at identical plasma glucose (PG) profiles (isoglycemia), is called the incretin effect. In t...
Eligibility Criteria
Inclusion
- Diagnosis of chronic pancreatitis with secondary diabetes mellitus
- Diagnosis of chronic pancreatitis with normal glucose tolerance
- Diagnosis of type 2 diabetes
- Normal level of hemoglobin
- Normal level of se-creatinine
Exclusion
- GAD-65 autoantibodies
- ICA autoantibodies
- Albuminuria
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2006
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT00638573
Start Date
January 1 2006
End Date
July 1 2006
Last Update
January 13 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Gentofte University Hospital
Hellerup, Copenhagen County, Denmark, 2900